Asset Dedication LLC’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Asset Dedication LLC’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13	Closed	-$1.35K	–	1273
2026 Q1	$1.35K	Hold	13	–	–	﹤0.01%	997
2025 Q4	$1.36K	Hold	13	–	–	﹤0.01%	1034
2025 Q3	$1.2K	Hold	13	–	–	﹤0.01%	1059
2025 Q2	$1.04K	Hold	13	–	–	﹤0.01%	1084
2025 Q1	$1.13K	Hold	13	–	–	﹤0.01%	1010
2024 Q4	$1.07K	Hold	13	–	–	﹤0.01%	1014
2024 Q3	$1.13K	Sell	13 -32	-71%	-$2.74K	﹤0.01%	1057
2024 Q2	$3.7K	Buy	45 +32	+246%	+$2.54K	﹤0.01%	984
2024 Q1	$1K	Hold	13	–	–	﹤0.01%	944
2023 Q4	$1K	Hold	13	–	–	﹤0.01%	952
2023 Q3	$1K	Hold	13	–	–	﹤0.01%	951
2023 Q2	$1K	Hold	13	–	–	﹤0.01%	922
2023 Q1	$1K	Buy	+13	New	+$1K	﹤0.01%	912
2017 Q2	–	Sell	-100	Closed	-$6K	–	390
2017 Q1	$6K	Hold	100	–	–	﹤0.01%	335
2016 Q4	$6K	Buy	+100	New	+$5.76K	﹤0.01%	332

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Asset Dedication LLC's PJP Position: Q2 2026 in Review

Asset Dedication LLC sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2026, closing a stake of 13 shares — an estimated $1.35K sold.

Asset Dedication LLC first reported a position in PJP in Q4 2016 and held it in 15 quarters. The position peaked at $6K in Q1 2017. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Asset Dedication LLC reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
Asset Dedication LLC sold 13 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $1.35K.
Asset Dedication LLC first reported a position in Invesco Pharmaceuticals ETF in Q4 2016 and held it in 15 quarters.
Asset Dedication LLC's Invesco Pharmaceuticals ETF position peaked at $6K in Q1 2017.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.